News

Investment support for UZ Leuven construction projects

6 June 2024

The Flemish government informed the press today that UZ Leuven can count on 14.7 million annual investment support for important infrastructure works. There are new building projects in the pipeline in Leuven that are important for both patients and staff.

New biomarker predicts success of immunotherapy in kidney cancer

21 May 2024

Immunotherapy increases survival rates in kidney cancer, but does not work for everyone. A Leuven research team developed a new method to predict which patients will benefit from it. Their study, published in the journal Nature Medicine, also opens new avenues to even more effective treatments.

First results gene therapy for frontotemporal degeneration are promising

14 May 2024

UZ Leuven has been collaborating on an internationl clinical study on gene replacement in FTD with progranulin mutation.

Cancer radiation during pregnancy safe for unborn child

18 April 2024

Cancer radiation during pregnancy is safe for the unborn child, a long-term study from UZ Leuven has shown. The research team brings long-term results of the psychological and physical impact on a child after radiotherapy in the mother during pregnancy for the first time.

New treatment successful for therapy-resistant ovarian cancer

4 April 2024

An international study led by UZ Leuven shows that ovarian cancer patients that are treated with an antibody in combination with chemotherapy survive longer than after a treatment with classic chemotherapy. This finding is a big step in the treatment of ovarian cancer.

UZ Leuven and CHU Luik to become external breast milk bank

19 March 2024

Belgium is getting two external breast milk banks: one at UZ Leuven and one at CHU Luik. These donor banks will not only help premature babies on their way in their own hospital, but also to provide other hospitals in Flanders and Wallonia with breast milk in future.

Role of pre-TCR-alfa in immunodeficiency further unraveled

8 March 2024

Leuven doctors colloborated on an international study that discovered that mutations in the gene for pre-TCR-α can lead to immunodeficencies and auto-immune diseases in some carriers. The results have been published in the scientific journal Science.

UZ Leuven best Belgian hospital in top 20 in Europe according to Newsweek ranking

5 March 2024

For the sixth year in a row, the American magazine Newsweek and the data platform Statista drew up a list of the world's best hospitals: World's Best Hospitals 2024. In it, UZ Leuven is the first Belgian hospital in position 44, achieving a top score of 93.17%.

Record number of liver transplants in 2023 at UZ Leuven

19 February 2024

In 2023 there was a record number of liver transplants at UZ Leuven. The remarkable increase is partly due to technological evolutions that allow the use of donor livers of people that died of a cardiac arrest. It also reduced the waiting list for liver transplants in 2023.

Five myths about epilepsy

12 February 2024

Did you know that more than 60,000 people in Belgium suffer from epilepsy and that the disorder is not that rare at all? And that an epileptic seizure is certainly not always accompanied by convulsions? Paediatric neurologist prof. dr. Katrien Jansen helps dispel five myths about epilepsy.

Allergy medication as treatment for irritable bowel syndrome

9 February 2024

Good news for patientst with irritable bowel syndrome: a recent study, coordinated by UZ Leuven, has shown that the allergy medication ebastine can reduce the symptoms of the disorder.

Leuven researchers find biomarker to predict success of immunotherapy in liver cancer

12 January 2024

Leuven researchers used single cell technology to look at the deepest level of the cells in the tumour and discovered a biomarker that can predict whether a patient with liver cancer will react to immunotherapy or not. The study was published in Nature Communications.